Individuals with a pathogenic variant in BRCA1, BRCA2, or PALB2 had a risk of breast cancer well above 20% at age 70, regardless of their PRS (Figure 3B) or family history (Figure 3E, Supplemental Table 10). This evidence concerns the gene PALB2 and breast carcinoma.